Cancer Immunology Program

Boehringer Ingelheim to Acquire Labor Dr. Merk & Kollegen to Strengthen its Next Generation Cancer Immunology Program

Ochsenhausen, Ingelheim am Rhein, Germany:  Boehringer Ingelheim has signed the agreement on the acquisition of all shares of Germany-based biotech…

Read More »